Bio Solution Co.,Ltd. (KOSDAQ:086820)

Bio Solution Statistics

Total Valuation

Bio Solution has a market cap or net worth of KRW 193.53 billion. The enterprise value is 210.64 billion.

Market Cap	193.53B
Enterprise Value	210.64B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Bio Solution has 24.13 million shares outstanding.

Current Share Class	24.13M
Shares Outstanding	24.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	18.87%
Owned by Institutions (%)	0.21%
Float	19.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.39
PB Ratio	4.15
P/TBV Ratio	4.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-164.21
EV / Sales	25.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-126.89

Financial Position

The company has a current ratio of 16.04, with a Debt / Equity ratio of 0.03.

Current Ratio	16.04
Quick Ratio	15.34
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.75
Interest Coverage	-59.17

Financial Efficiency

Return on equity (ROE) is -2.71% and return on invested capital (ROIC) is -3.62%.

Return on Equity (ROE)	-2.71%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-3.62%
Return on Capital Employed (ROCE)	-5.87%
Revenue Per Employee	116.55M
Profits Per Employee	-18.07M
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.98% in the last 52 weeks. The beta is 0.62, so Bio Solution's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+41.98%
50-Day Moving Average	8,618.40
200-Day Moving Average	8,927.93
Relative Strength Index (RSI)	42.83
Average Volume (20 Days)	44,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bio Solution had revenue of KRW 8.27 billion and -1.28 billion in losses. Loss per share was -53.69.

Revenue	8.27B
Gross Profit	4.70B
Operating Income	-2.80B
Pretax Income	-1.28B
Net Income	-1.28B
EBITDA	-964.75M
EBIT	-2.80B
Loss Per Share	-53.69

Balance Sheet

The company has 36.42 billion in cash and 1.24 billion in debt, giving a net cash position of 35.18 billion or 1,457.93 per share.

Cash & Cash Equivalents	36.42B
Total Debt	1.24B
Net Cash	35.18B
Net Cash Per Share	1,457.93
Equity (Book Value)	46.62B
Book Value Per Share	1,949.39
Working Capital	38.67B

Cash Flow

In the last 12 months, operating cash flow was -912.77 million and capital expenditures -747.23 million, giving a free cash flow of -1.66 billion.

Operating Cash Flow	-912.77M
Capital Expenditures	-747.23M
Free Cash Flow	-1.66B
FCF Per Share	-68.79

Margins

Gross margin is 56.82%, with operating and profit margins of -33.80% and -15.50%.

Gross Margin	56.82%
Operating Margin	-33.80%
Pretax Margin	-15.50%
Profit Margin	-15.50%
EBITDA Margin	-11.66%
EBIT Margin	-33.80%
FCF Margin	n/a

Dividends & Yields

Bio Solution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.40%
Shareholder Yield	-1.40%
Earnings Yield	-0.66%
FCF Yield	-0.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 27, 2025. It was a forward split with a ratio of 3.

Last Split Date	May 27, 2025
Split Type	Forward
Split Ratio	3

Scores

Bio Solution has an Altman Z-Score of 36.49 and a Piotroski F-Score of 2.

Altman Z-Score	36.49
Piotroski F-Score	2